Yaxin Wang

Yaxin Wang

Auto-generated profile, based on publicly available information

Yaxin Wang

Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Endocrine
Verified
Journal Article
Open access
PDF file
WHWeifeng Huang
Weifeng Huang
SLSiwan Li
Siwan Li
JLJingyi Lu
Jingyi Lu
YSYun Shen
Yun Shen
YWYaxin Wang
Yaxin Wang
YLyingchuan li
yingchuan li
Objective Continuous glucose monitoring (CGM) has the potential to improve glucose control in the intensive care unit (ICU) setting. We sought to evaluate the accuracy of the intermittently scanned CGM (isCGM) system in critically ill patients. Research design and methods Adult patients were consecutively enrolled from three ICUs from August 2020 to January 2021. The performance of FreeStyle Libre Pro was evaluated against the venous blood glucose samples as a reference. Numerical accuracy was examined by the mean absolute relative difference (MARD), the Bland–Altman analysis, and the International Organization for Standardization criteria. Clinical accuracy was assessed by performing the Clarke and consensus error grid analysis. Results A total of 122 patients were included and 3416 matched glucose pairs were analyzed. The overall MARD was 18.0%, and the highest MARD (33.1%) was observed in the hypoglycemic range (<70 mg/dL). The Bland–Altman analysis revealed a mean bias of −11.7 mg/dL, with the 95% limits of agreement of −73.0 to 49.5 mg/dL. The percentages of isCGM glucose values within ±15%/15, ±20%/20, and ±30%/30 mg/dL were 49.8%, 64.7%, and 84.5%, respectively. The Clarke and consensus error grid analysis showed acceptable clinical accuracy with 98.5% and 98.8% of glucose values falling into zones A and B. Conclusions Our study demonstrated suboptimal overall accuracy of isCGM for critically ill patients. Whether the adjunctive use of isCGM could improve glucose management and health outcomes in the critically ill needs further investigation. Clinical trial registration ChiCTR2100042036, Chinese Clinical Trial Registry.

18 July 2024 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
MGMing Gong
Ming Gong
BSBryan Richard Sasmita
Bryan Richard Sasmita
YZYuansong Zhu
Yuansong Zhu
SCSiyu Chen
Siyu Chen
YWYaxin Wang
Yaxin Wang
BHbi huang
bi huang
Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) carries a high mortality risk. Inflammation and nutrition are involved in the pathogenesis and prognosis of both AMI and CS. The advanced lung cancer inflammation index ratio (ALI) combines the inflammatory and nutritional status. Our present study aimed to explore the prognostic value of ALI in patients with CS following AMI. Methods: In total, 217 consecutive patients with AMI complicated by CS were divided into two groups based on the ALI admissions cut-off: ≤12.69 and >12.69. The primary endpoint of this study was 30-day all-cause mortality. The secondary endpoints were gastrointestinal hemorrhage and major adverse cardiovascular events (MACEs), including 30-day all-cause mortality, atrioventricular block, ventricular tachycardia/ventricular fibrillation, and nonfatal stroke. The association of ALI with the study endpoints was analyzed by Cox regression analysis. Results: During the 30-day follow-up period after admission, 104 (47.9%) patients died and 150 (69.1%) suffered MACEs. The Kaplan–Meier analysis revealed significantly higher cumulative mortality and lower MACE rates in the low-ALI group compared to the high-ALI group (both log-rank p < 0.001). The 30-day mortality rate was significantly higher in patients with ALI ≤12.69 compared to ALI >12.69 (72.1% vs. 22.6%; p < 0.001). Furthermore, the incidence of MACEs was higher in patients with ALI ≤12.69 (85.6% vs. 51.9%; p < 0.001). The receiver operating curve showed that ALI had a modest predictive value (area under the curve [AUC]: 0.789, 95% confidence interval [CI]: 0.729, 0.850). After multivariable adjustment, ALI ≤12.69 was an independent predictor for both 30-day all-cause mortality (hazard ratio [HR]: 3.327; 95% CI: 2.053, 5.389; p < 0.001) and 30-day MACEs (HR: 2.250; 95% CI 1.553, 3.260; p < 0.001). Furthermore, the addition of ALI to a base model containing clinical and laboratory data statistically improved the predictive value. Conclusions: Assessing ALI levels upon admission can provide important information for the short-term prognostic assessment of patients with AMI complicated by CS. A lower ALI may serve as an independent predictor of increased 30-day all-cause mortality and MACEs.

15 October 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XZXiaowen Zhou
Xiaowen Zhou
JLJingbiao Luo
Jingbiao Luo
SLShuxian Lin
Shuxian Lin
YWYaxin Wang
Yaxin Wang
ZYZhenqian Yan
Zhenqian Yan
XLXiaotao Li
Xiaotao Li
Hyperlipidemia, a common metabolic disease, is a risk factor for cardiovascular diseases, Poria cocos (PC) and Alismatis rhizoma (AR) serve as a potential treatment. A systematic approach based on transcriptome sequencing analysis and bioinformatics methods was developed to explore the synergistic effects of PC–AR and identify major compounds and potential targets. The phenotypic characteristics results indicated that the high dose (4.54 g/kg) of PC–AR reduced total cholesterol (TC), elevated high-density lipoprotein cholesterol (HDL-C) levels, and improved hepatocyte morphology, as assessed via hematoxylin and eosin (H&E) staining. Transcriptomic profiling processing results combined with GO enrichment analysis to identify the overlapping genes were associated with inflammatory responses. The cytokine-cytokine receptor interaction pathway was found as a potential key pathway using geneset enrichment analysis. Core enrichment targets were selected according to the PC–AR's fold change versus the model. Real-time quantitative PCR analysis validated that PC–AR significantly downregulated the expression of Cxcl10, Ccl2, Ccl4, Cd40 and Il-1β mRNA (P < 0.05). Molecular docking analysis revealed the significant compounds of PC–AR and the potential binding patterns of the critical compounds and targets. This study provides further evidence that the therapeutic effects of PC–AR on hyperlipidemia in rats through the regulation of inflammation-related targets.

9 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XZXiaowen Zhou
Xiaowen Zhou
ZYZhenqian Yan
Zhenqian Yan
YWYaxin Wang
Yaxin Wang
QRQi Ren
Qi Ren
XLXiaoqi Liu
Xiaoqi Liu
XLXiaotao Li
Xiaotao Li
Background. Hyperlipidemia, due to the practice of unhealthy lifestyles of modern people, has been a disturbance to a large portion of population worldwide. Recently, several scholars have turned their attention to Chinese medicine (CM) to seek out a lipid-lowering approach with high efficiency and low toxicity. This study aimed to explore the mechanism of Huatan Jiangzhuo decoction (HTJZD, a prescription of CM) in the treatment of hyperlipidemia and to determine the major regulation pathways and potential key targets involved in the treatment process. Methods. Data on the compounds of HTJZD, compound-related targets (C-T), and known disease-related targets (D-T) were collected from databases. The intersection targets (I-T) between C-T and D-T were filtered again to acquire the selected targets (S-T) according to the specific index. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, as well as network construction, were applied to predict the putative mechanisms of HTJZD in treating hyperlipidemia. Thereafter, an animal experiment was conducted to validate the therapeutic effect of HTJZD. In addition, regulated differentially expressed genes (DEGs) were processed from the RNA sequencing analysis results. Common genes found between regulated DEGs and S-T were analyzed by KEGG pathway enrichment to select the key targets. Lastly, key targets were validated by real-time quantitative reverse transcription PCR (qRT-PCR) analysis. Results. A total of 210 S-T were filtered out for enrichment analysis and network construction. The enrichment results showed that HTJZD may exert an effect on hyperlipidemia through the regulation of lipid metabolism and insulin resistance. The networks predict that the therapeutic effect of HTJZD may be based on the composite pharmacological action of these active compounds. The animal experiment results verify that HTJZD can inhibit dyslipidemia in rats with hyperlipidemia, suppress lipid accumulation in the liver, and reverse the expression of 202 DEGs, which presented an opposite trend in the model and HTJZD groups. Six targets were selected from the common targets between 210 S-T and 202 regulated DEGs, and the qRT-PCR results showed that HTJZD could effectively reverse Srebp-1c, Cyp3a9, and Insr mRNA expression (P<0.01). Conclusion. In brief, network pharmacology predicted that HTJZD exerts a therapeutic effect on hyperlipidemia. The animal experimental results confirmed that HTJZD suppressed the pathological process induced by hyperlipidemia by regulating the expression of targets involved in lipid metabolism and insulin resistance.

16 November 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
GFGe Fang
Ge Fang
YWYaxin Wang
Yaxin Wang
ZYZhenqian Yan
Zhenqian Yan
XZXiaowen Zhou
Xiaowen Zhou
XFXingyu Fan
Xingyu Fan
XLXiaotao Li
Xiaotao Li
Background. Damp phlegm and blood stasis pattern (DPBSP) is the main pattern in coronary heart disease (CHD) patients. To quantify and standardize the diagnosis of DPBSP, questionnaires are usually administered. The CHD Damp Phlegm and Blood Stasis Pattern Questionnaire (CHD-DPBSPQ) is the standard metric for measuring CHD-DPBSP signs and symptoms in practice and clinical research. The CHD-DPBSPQ has moderate diagnostic efficiency, as evidenced by its receiver operating characteristic curves. Furthermore, and high reliability and validity have been shown in some studies but not in a multicenter clinical trial. Our purpose was to evaluate the test-retest reliability of a proprietary CHD-DPBSPQ. Methods. The CHD-DPBSPQ uses a standard procedure for measuring symptoms. The (interrater) reliability and validity of this questionnaire have been previously studied. Here, we evaluated the test interval and weighted kappa value of items of test-retest (intrarater) reliability of the CHD-DPBSPQ. The test-retest reliability was evaluated by the intraclass correlation coefficient (ICC) for the total CHD-DPBSPQ score and the phlegm domain and blood stasis domain scores. Weighted kappa statistics were calculated for the individual CHD-DPBSPQ items. Results. Using the CHD-DPBSPQ, 79 patients with late-stage CHD who were participating in a multicenter clinical trial were assessed twice. The ICCs for the CHD-DPBSPQ score were as follows: 0.827 for the total CHD-DPBSPQ, 0.778 for the phlegm domain score, and 0.828 for the blood stasis domain score. The reliability was slightly better in patients whose test interval was 14 days. The weighted kappa values of individual items showed moderate consistency. Conclusions. The CHD-DPBSPQ was found to have excellent test-retest reliability in this sample of patients.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
XZXiaowen Zhou
Xiaowen Zhou
JLJingbiao Luo
Jingbiao Luo
SLShuxian Lin
Shuxian Lin
YWYaxin Wang
Yaxin Wang
ZYZhenqian Yan
Zhenqian Yan
XLXiaotao Li
Xiaotao Li
Ethnopharmacological relevancePoria cocos (Poria cocos (Schw.) Wolf, Fuling in Chinese, simplified as FL) and Alismatis Rhizoma (Alisma plantago-aquatica subsp. orientale (Sam.) Sam., Zexie in Chinese, simplified as ZX) are the Chinese herbs which firstly recorded in the Shennong’s Classic of Materia Medica and listed as the top graded medicine. They have been used for more than 2000 years in China. According to traditional Chinese Medicine (TCM) theory, combination of FL and ZX has the effect on invigorating the spleen to eliminate the dampness. Modern pharmacological studies display that FL or (and) ZX could reduce cholesterol, with more research on the single herb than the combination, but the underlying mechanisms remains unclear. The aim of this studyTo investigate the therapeutic and underlying mechanism of herbal pair FL/ZX on diet induced hyperlipidemia in rats.Material and methodsThe hyperlipoidemia model was established by fed with high-lipid fodder. The effects of herbal pair FL/ZX on diet-induced hyperlipidemia rats were assessed by comparing the phenotypic characteristics, serum lipids, Lee’s index and liver pathological changes of the normal control rats (C), HLP rat model (M), and herbal Pair FL/ZX intervened rats (FL/ZX). Subsequently, applied liver transcriptomics profiling to screen differentially expressed genes (DEGs). The potential targets and mechanisms of FL/ZX in the treatment of HLP were analyzed by bioinformatics methods. Finally, the potential targets were verified by western blotting analysis.ResultsThe results demonstrated herbal pair FL/ZX could improve the phenotypic characteristics of hyperlipidemia, and the high dose FL/ZX significantly improved serum lipids and the pathological morphology of hepatocytes. Transcriptome analysis showed there were 2502 DEGs (1704 up-regulated and 798 down-regulated) in comparing groups M versus C, 1210 DEGs (434 up-regulated and 776 down-regulated) in M vs. FL/ZX, and 622 overlapped genes between M vs. C and M vs. FL/ZX. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, Gene Set Enrichment Analysis (GSEA) and protein-protein interaction (PPI) networks construction of the overlapped genes were implicated in immune and inflammatory response. Western blotting analysis indicated the five targets (Cxcl10, Stat1, Ccl2, Cd40 and Tlr2) at protein levels were consistent with that obtained from transcriptomic data, although the fold changes in the expression level differed.ConclusionsThe herbal pair FL/ZX might attenuate HLP possibly by affecting immune and inflammatory response-related pathways. DEGs involved in the immune system-related signaling pathway such as Stat1, Tlr2, Cd40, Cxcl10 and Ccl2 are might be the candidate targets for the herbal pair FL/ZX in the treatment of HLP.